The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo

被引:106
作者
Duncan, GS
Mittrucker, HW
Kagi, D
Matsuyama, T
Mak, TW
机构
[1] AMGEN INST, TORONTO, ON M5G 2M9, CANADA
[2] UNIV TORONTO, ONTARIO CANC INST, DEPT IMMUNOL, TORONTO, ON M4X 1K9, CANADA
[3] UNIV TORONTO, DEPT MED BIOPHYS, TORONTO, ON M4X 1K9, CANADA
关键词
D O I
10.1084/jem.184.5.2043
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The activation of natural killer (NK) cells, cytotoxic lymphocytes capable of major histocompatibility complex (MHC)-unrestricted killing and early antiviral defense, is temporally related to the increased interferon (IFN)-alpha/beta production that is seen in the viral infection of mice. Type I IFN (IFN-alpha/beta) are expressed in many cell types early after primary viral infection and have been shown to mediate resistance against a variety of viruses. In this study, the role of the transcriptional activator IFN regulatory factor-1 (IRF-1) in murine NK cell activity was assessed. IRF-1-deficient mice displayed a normal frequency of NK marker-positive cells, but exhibited greatly reduced NK cell-mediated cytotoxicity after both virus infection and stimulation with the IFN inducer polyinosinic:polycytidilic acid in vivo. In vitro, cytolytic activity in IRF-1-deficient NK cells remained defective after stimulation with IFN-beta, IL-2, and IL-12. IRF-1-deficient mice were unable to eliminate syngeneic MHC class I-negative tumor cells in vivo, and had a reduced ability to reject parental semi-allogeneic donor cells from the circulation. Thus, IRF-1 is essential for the induction of NK cell-mediated cytotoxicity and for the in vivo effector functions that are mediated by this activity.
引用
收藏
页码:2043 / 2048
页数:6
相关论文
共 24 条
  • [1] CYTOKINES IN THE GENERATION OF IMMUNE-RESPONSES TO, AND RESOLUTION OF, VIRUS-INFECTION
    BIRON, CA
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (04) : 530 - 538
  • [2] INDUCTION OF INTERFERON-GAMMA PRODUCTION BY NATURAL-KILLER-CELL STIMULATORY FACTOR - CHARACTERIZATION OF THE RESPONDER CELLS AND SYNERGY WITH OTHER INDUCERS
    CHAN, SH
    PERUSSIA, B
    GUPTA, JW
    KOBAYASHI, M
    POSPISIL, M
    YOUNG, HW
    WOLF, SF
    YOUNG, D
    CLARK, SC
    TRINCHIERI, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (04) : 869 - 879
  • [3] MULTIPLE DEFECTS OF IMMUNE CELL-FUNCTION IN MICE WITH DISRUPTED INTERFERON-GAMMA GENES
    DALTON, DK
    PITTSMEEK, S
    KESHAV, S
    FIGARI, IS
    BRADLEY, A
    STEWART, TA
    [J]. SCIENCE, 1993, 259 (5102) : 1739 - 1742
  • [4] INDUCTION OF THE TRANSCRIPTION FACTOR IRF-1 AND INTERFERON-BETA MESSENGER-RNAS BY CYTOKINES AND ACTIVATORS OF 2ND-MESSENGER PATHWAYS
    FUJITA, T
    REIS, LFL
    WATANABE, N
    KIMURA, Y
    TANIGUCHI, T
    VILCEK, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (24) : 9936 - 9940
  • [5] ABSENCE OF THE TYPE-I IFN SYSTEM IN EC CELLS - TRANSCRIPTIONAL ACTIVATOR (IRF-1) AND REPRESSOR (IRF-2) GENES ARE DEVELOPMENTALLY REGULATED
    HARADA, H
    WILLISON, K
    SAKAKIBARA, J
    MIYAMOTO, M
    FUJITA, T
    TANIGUCHI, T
    [J]. CELL, 1990, 63 (02) : 303 - 312
  • [6] STRUCTURALLY SIMILAR BUT FUNCTIONALLY DISTINCT FACTORS, IRF-1 AND IRF-2, BIND TO THE SAME REGULATORY ELEMENTS OF IFN AND IFN-INDUCIBLE GENES
    HARADA, H
    FUJITA, T
    MIYAMOTO, M
    KIMURA, Y
    MARUYAMA, M
    FURIA, A
    MIYATA, T
    TANIGUCHI, T
    [J]. CELL, 1989, 58 (04) : 729 - 739
  • [7] INTERLEUKIN-2 AUGMENTS NATURAL-KILLER CELL-ACTIVITY
    HENNEY, CS
    KURIBAYASHI, K
    KERN, DE
    GILLIS, S
    [J]. NATURE, 1981, 291 (5813) : 335 - 338
  • [8] CYTOTOXICITY MEDIATED BY T-CELLS AND NATURAL-KILLER-CELLS IS GREATLY IMPAIRED IN PERFORIN DEFICIENT MICE
    KAGI, D
    LEDERMANN, B
    BURKI, K
    SEILER, P
    ODERMATT, B
    OLSEN, KJ
    PODACK, ER
    ZINKERNAGEL, RM
    HENGARTNER, H
    [J]. NATURE, 1994, 369 (6475) : 31 - 37
  • [9] REQUIREMENT FOR TRANSCRIPTION FACTOR IRF-1 IN NO SYNTHASE INDUCTION IN MACROPHAGES
    KAMIJO, R
    HARADA, H
    MATSUYAMA, T
    BOSLAND, M
    GERECITANO, J
    SHAPIRO, D
    LE, J
    KOH, SI
    KIMURA, T
    GREEN, SJ
    MAK, TW
    TANIGUCHI, T
    VILCEK, J
    [J]. SCIENCE, 1994, 263 (5153) : 1612 - 1615
  • [10] SELECTIVE REJECTION OF H-2-DEFICIENT LYMPHOMA VARIANTS SUGGESTS ALTERNATIVE IMMUNE DEFENSE STRATEGY
    KARRE, K
    LJUNGGREN, HG
    PIONTEK, G
    KIESSLING, R
    [J]. NATURE, 1986, 319 (6055) : 675 - 678